Esthetics International Group (5081) fair value: what the stock is really worth
As of Oct 13, 2026: fair value of Esthetics International Group MYR 0.13, price MYR 0.18, upside -25.7%, quality 63 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.
How to read this chart
60‑month range 0.1750 MYR – 0.7825 MYR · fair‑value band 0.1200 MYR – 0.1400 MYR · the 0.1750 MYR price screens above the 0.1300 MYR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 2 fiscal years are left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Oct 3, 2026.
Follow Esthetics International in your weekly email
Every Wednesday you see whether Esthetics International is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Esthetics International Group Berhad, an investment holding company, operates as a beauty and wellness company in Malaysia, Singapore, Hong Kong, Indonesia, and Thailand. It operates through Professional Services and Sales, Product Distribution, E-Commerce, and Others segments.
Show more
Esthetics International Group Berhad, an investment holding company, operates as a beauty and wellness company in Malaysia, Singapore, Hong Kong, Indonesia, and Thailand. It operates through Professional Services and Sales, Product Distribution, E-Commerce, and Others segments. The company distributes skincare products, haircare products, hair tools, makeup products, aromatherapy products, and skin care equipment under Davines, GHD, Jane Iredale, Tisserand, and Dermalogica brands. It also develops and distributes daily enzyme drink under the Bioxil Innertreats brand; and fast-moving consumer goods skin care products under the Clinelle and Nurish Organiq brands. In addition, the company operates beauty and wellness centers; provides beauty and wellness services, as well as education and training in beauty and wellness, and management services; operates as an agent for trademarks and patents applications; retails beauty and wellness products through e-commerce; and invests in properties. Further, it owns and operates corporate outlets comprising AsterSpring skin care salons, and retail stores and department store counters. The company distributes its products through independent professional skincare, haircare salons, medispas, and aesthetic clinics. The company was incorporated in 1996 and is headquartered in Shah Alam, Malaysia. Esthetics International Group Berhad is a subsidiary of Providence Capital Sdn Bhd.
Stock analysis
Esthetics International Group (5081) currently trades at 0.1750 MYR, while our model-based Fair Value estimate is 0.1300 MYR, 25.7% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 1.18 MYR per share, and 10 of the 16 models we run sit above the 0.1750 MYR price.
Bear case: the Dividend Discount group reads lowest at 0.0600 MYR, and 6 of the 16 models stay below the price. Evidence for this calculation is low.
Scenario range: 0.1200 MYR (bear) to 0.1400 MYR (bull), the price of 0.1750 MYR sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 63/100 (solid quality), in the Consumer Defensive sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Esthetics International Group reported revenue of 195M MYR in FY2026 versus 125M MYR in FY2022, a compound +11.8%/yr. Reported net income was −3.3M MYR in FY2026.
Key figures
Market cap 41.5M MYR (≈ $10.2M) · P/S ratio 0.22 · EPS (TTM) −0.0100 MYR · Dividend yield 2.8% · Net margin −1.7% · Return on equity −1.9% · Return on assets (EBIT) −1.1% · Operating margin 3.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 43 out of 100 (low confidence).
What moves the price
The share trades about 31% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at −28% fair-value upside, at −26%, 5081 screens cheaper than that median.
Fair Value models
Bear 0.1200 MYRFair Value 0.1300 MYRBull 0.1400 MYR
Price 0.1750 MYR · Upside -25.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.54/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+6.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.5%
Start year 2021 (pandemic). Over 10 years: +2.1% a year
Revenue growth 14 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.8%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
1.3% (2021) → 0.3% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
Compare Esthetics International Group with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Household & Personal Products · 240 stocks
Beats the industry median on 4/11 measures
Overall it trails its industry peers.
Valuation
Quality Score63 · Above median
Fair Value upside−35.0% · Below median
Profitability
Return on assets0.2% · Bottom 25%
Net margin (TTM)−1.5% · Bottom 25%
Operating margin (TTM)3.7% · Below median
Growth and dividend
Revenue growth−3.3% · Below median
Dividend yield (TTM)2.8% · Below median
Balance sheet
Debt / equity0.09× · Above median
Valuation Multiplesvs Household & Personal Products median · lower = cheaper
P/B0.08× · Cheapest 25%
P/S (TTM)0.06× · Cheapest 25%
P/FCF0.4× · Cheapest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 29
FUTURE (revenue growth)0· sector 19
PAST (return on equity)0· sector 30
HEALTH (low debt)96· sector 98
DIVIDEND (yield)56· sector 56
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Esthetics International Group Fair Value". https://www.fairvalue-calculator.com/stock/5081
Frequently asked questions
Is Esthetics International Group (5081) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of 0.1300 MYR versus a price of 0.1750 MYR, about −26% upside (overvalued).
What is the fair value of 5081?
Our model-based fair value for Esthetics International Group is 0.1300 MYR (as of Oct 3, 2026), built from audited fundamentals. The current price: 0.1750 MYR.
What is the quality score of 5081?
Esthetics International Group has a Quality Score of 63/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Esthetics International Group (5081)?
Our model-based price target is the fair value of 0.1300 MYR (as of Oct 3, 2026) from 16 valuation models. Cautious scenario 0.1200 MYR, optimistic scenario 0.1400 MYR. It is a calculation from audited fundamentals, not an analyst target.
What is the Esthetics International Group stock forecast for 2026?
Our models put fair value at 0.1300 MYR, about −26% upside versus a price of 0.1750 MYR (overvalued). Cautious scenario 0.1200 MYR, optimistic scenario 0.1400 MYR. The calculation is refreshed regularly with new filings.
What is the revenue of Esthetics International Group (5081)?
Esthetics International Group reported trailing-twelve-month revenue of about 193M MYR (latest available figure, as of Oct 3, 2026).
Does Esthetics International Group pay a dividend?
Esthetics International Group currently shows a dividend yield of about 2.78% relative to its recent price (as of Oct 3, 2026).
What is the intrinsic value of Esthetics International Group (5081)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Esthetics International Group it is 0.1300 MYR per share (as of Oct 3, 2026), against a price of 0.1750 MYR. It is the blended result of 16 valuation models (cash flow, earnings, asset, dividend).
Is Esthetics International Group stock overvalued or undervalued in 2026?
As of Oct 3, 2026, 5081 trades above its calculated fair value: price 0.1750 MYR, fair value 0.1300 MYR, a gap of about −26% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 5081?
No. The price is what the market pays today (0.1750 MYR); the fair value is what the company's own numbers justify (0.1300 MYR). For Esthetics International Group the two are 0.0450 MYR per share apart. That gap is exactly why we show both numbers side by side.
How much is Esthetics International Group worth?
The market values Esthetics International Group at about 41.5M MYR (market capitalisation, as of Oct 3, 2026). Per share that is 0.1750 MYR; our models calculate a fair value of 0.1300 MYR per share.
What do the bullish and bearish scenarios say about 5081?
Our models span a range for Esthetics International Group: cautious scenario 0.1200 MYR, base 0.1300 MYR, optimistic 0.1400 MYR per share (as of Oct 3, 2026, price 0.1750 MYR). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Esthetics International Group (5081)?
Balance-sheet figures for Esthetics International Group (as of Oct 3, 2026): return on equity −1.9%, debt of 0.09 per unit of equity. They feed the Quality Score of 63/100, which measures business quality independently of the share price.
How far is 5081 from its 52-week high?
Esthetics International Group trades at 0.1750 MYR, about 31% below its 52-week high of 0.2550 MYR and at the low of 0.1750 MYR (as of Oct 13, 2026). Distance from the high says nothing about value: that is what the fair value of 0.1300 MYR is for.
Which stocks are comparable to Esthetics International Group?
From the same area (Consumer Defensive) we also value Colgate-Palmolive Company, Hindustan Unilever Limited, Kenvue Inc, The Estée Lauder Companies Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Esthetics International Group stock attractive at the current price?
The data as of Oct 3, 2026: price 0.1750 MYR, calculated fair value 0.1300 MYR (−26%), Quality Score 63/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 5081 calculated?
We run Esthetics International Group through 16 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 0.1300 MYR, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.8 % above its aggregate fair value. Esthetics International Group itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Esthetics International Group (5081)?
The closing price on Oct 13, 2026 was 0.1750 MYR. Our model-based fair value is 0.1300 MYR, about −26% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Esthetics International Group right now?
The price sits above even our optimistic bull case (0.1400 MYR). The favourable scenario is already priced in. Solid but not exceptional quality (63/100) and above fair value, neither a clear bargain nor a standout compounder. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Esthetics International Group
How large is the market capitalisation of Esthetics International Group (5081)?
The market capitalisation of Esthetics International Group is 41.5M MYR (≈ $10.2M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Esthetics International Group (5081)?
The price-to-sales ratio of Esthetics International Group is 0.22 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Esthetics International Group (5081)?
Earnings per share at Esthetics International Group are −0.0100 MYR. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Esthetics International Group (5081)?
The dividend yield of Esthetics International Group is 2.8%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Esthetics International Group (5081)?
The net margin of Esthetics International Group is −1.7% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Esthetics International Group (5081)?
The return on equity (ROE) of Esthetics International Group is −1.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Esthetics International Group (5081)?
On an EBIT basis the return on assets of Esthetics International Group is −1.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Esthetics International Group (5081)?
The operating margin of Esthetics International Group is 3.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Esthetics International Group (5081)?
Revenue at Esthetics International Group is growing −3.3% versus a year earlier (3y avg +5.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Esthetics International Group (5081)?
Earnings per share at Esthetics International Group are growing +662% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Esthetics International Group (5081) generate?
The free cash flow of Esthetics International Group is 31.6M MYR (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed
Watch Esthetics International Group in the live analysis
One click puts Esthetics International Group on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener.
